Main Industry
Biotechnology
Main Product/Service
The core products and services of GlycoGenetics include: recombinant human lectin reagents for cell‑surface glycoprofiling; lectin array and flow cytometry platforms for glycan characteristic analysis; and discovery services for biomarkers and drug target
Founded Year
2017
Unified Business No.
55688209
Status
Active
Number of Employees
0
Total Paid-in
Capital
500,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
GlycoGenetics, Inc., founded in 2017 and headquartered in Zhongshan District, Taipei City, Taiwan, is a biotechnology company focused on glycobiology. Leveraging genetic engineering and synthetic biology, the company deciphers the complex glycocode of human biology and develops molecular tools and platforms to accelerate the application of glycomics in basic research, clinical diagnostics and bioprocessing.
